Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.28−0.02 (-5.95%)
Close on Nov 20, 2026Market cap $2.28MP/E –Yield –
Q/C Technologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Q/C Technologies's free cash flow for the twelve months ending Dec 31, 2018 was -$8.57M. For fiscal 2025 it was -$10.82M. The highest annual figure on record is -$2.85M in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.82M | – |
| FY2018 | Dec 31, 2018 | -$8.57M | – |
| FY2017 | Dec 31, 2017 | -$5.13M | – |
| FY2016 | Dec 31, 2016 | -$4.30M | – |
| FY2015 | Dec 31, 2015 | -$5.25M | – |
| FY2014 | Dec 31, 2014 | -$3.91M | – |
| FY2013 | Dec 31, 2013 | -$2.85M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | -$2.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.06M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.84M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.58M | – |
| Q4 FY2016 | Dec 31, 2016 | -$674.78K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.12M | – |
| Q2 FY2016 | Jun 30, 2016 | -$725.93K | – |
| Q1 FY2016 | Mar 31, 2016 | -$1.80M | – |
See a number that looks wrong?